Cargando…
The methyl-CpG-binding domain 2 facilitates pulmonary fibrosis by orchestrating fibroblast to myofibroblast differentiation
Although DNA methylation has been recognised in the pathogenesis of idiopathic pulmonary fibrosis (IPF), the exact mechanisms are yet to be fully addressed. Herein, we demonstrate that lungs originated from IPF patients and mice after bleomycin (BLM)-induced pulmonary fibrosis are characterised by a...
Autores principales: | Wang, Yi, Zhang, Lei, Huang, Teng, Wu, Guo-Rao, Zhou, Qing, Wang, Fa-Xi, Chen, Long-Min, Sun, Fei, Lv, Yongman, Xiong, Fei, Zhang, Shu, Yu, Qilin, Yang, Ping, Gu, Weikuan, Xu, Yongjian, Zhao, Jianping, Zhang, Huilan, Xiong, Weining, Wang, Cong-Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520034/ https://www.ncbi.nlm.nih.gov/pubmed/35086828 http://dx.doi.org/10.1183/13993003.03697-2020 |
Ejemplares similares
-
Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-β-induced fibroblast to myofibroblast differentiation
por: Liu, Peng, et al.
Publicado: (2020) -
Correction to: Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-β-induced fibroblast to myofibroblast differentiation
por: Liu, Peng, et al.
Publicado: (2023) -
Local administration of liposomal-based Srpx2 gene therapy reverses pulmonary fibrosis by blockading fibroblast-to-myofibroblast transition
por: Wang, Qi, et al.
Publicado: (2021) -
Local administration of liposomal-based Srpx2 gene therapy reverses pulmonary fibrosis by blockading fibroblast-to-myofibroblast transition: Erratum
por: Wang, Qi, et al.
Publicado: (2022) -
MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program
por: Wang, Yi, et al.
Publicado: (2021)